Arunjyoti Bio Ventures Limited Reports Substantial Share Sale by Chennupati Sarath Kumar
Arunjyoti Bio Ventures Limited disclosed a substantial share sale by Chennupati Sarath Kumar, who sold 60,97,684 equity shares (3.27% stake) through open market transactions between March 23-April 10, 2026. His shareholding reduced from 10.84% to 7.57%. The company's equity capital remains Rs. 18,63,81,000 with 18,63,81,000 shares of Re. 1/- each.
*this image is generated using AI for illustrative purposes only.
Arunjyoti bio ventures Limited has filed a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, reporting a significant share sale transaction by Chennupati Sarath Kumar. The disclosure, dated April 11, 2026, was submitted to BSE Limited where the company's shares are listed.
Transaction Details
Chennupati Sarath Kumar, who is not part of the promoter or promoter group, sold a substantial portion of his shareholding in the company through open market transactions. The sale was executed over a period spanning from March 23, 2026, to April 10, 2026.
| Transaction Parameter: | Details |
|---|---|
| Shares Sold: | 60,97,684 equity shares |
| Percentage of Total Capital: | 3.27% |
| Transaction Mode: | Open Market |
| Transaction Period: | March 23, 2026 to April 10, 2026 |
| Seller Category: | Non-Promoter |
Shareholding Pattern Changes
The transaction resulted in a significant reduction in Chennupati Sarath Kumar's stake in Arunjyoti Bio Ventures Limited. His shareholding position changed substantially following the completion of the sale.
| Shareholding Details: | Before Sale | After Sale | Change |
|---|---|---|---|
| Number of Shares: | 2,01,98,822 | 1,41,01,138 | -60,97,684 |
| Percentage Holding: | 10.84% | 7.57% | -3.27% |
Company Capital Structure
The company's equity share capital structure remained unchanged following this transaction. Arunjyoti Bio Ventures Limited maintains its existing capital base without any alterations to the total number of shares or their face value.
| Capital Structure: | Details |
|---|---|
| Total Equity Capital: | Rs. 18,63,81,000 |
| Number of Shares: | 18,63,81,000 |
| Face Value per Share: | Re. 1/- |
| Listing Exchange: | BSE Limited |
Regulatory Compliance
The disclosure was made in compliance with SEBI regulations governing substantial acquisition and disposal of shares. The transaction falls under the purview of Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, which mandates disclosure when shareholding changes exceed specified thresholds. The filing ensures transparency and keeps investors informed about significant changes in shareholding patterns of listed companies.
Historical Stock Returns for Arunjyothi Bio Ventures
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +5.69% | +50.23% | +30.85% | -10.79% | -8.72% | +6,928.57% |
What strategic factors might have motivated Chennupati Sarath Kumar to reduce his stake by over 3% during this specific timeframe?
How could this significant share sale impact Arunjyoti Bio Ventures' stock price and trading volumes in the coming weeks?
Will other major shareholders follow suit with similar divestments, potentially signaling broader market sentiment about the biotech sector?
20
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
